Radiolabeled anxA5 has been evaluated in clinical studies [8] and the clinical experience, although promising, indicate that the anxA5 imaging protocol requires improvement in order to be applicable to a broad range of cancer types and treatment regimens [16]. The gene discussed is ANXA5; the disease is cancer.